Emicizumab injection (vial) used to prevent bleeding episodes in people with hemophilia A
Contains emicizumab 60mg/0.4ml, a bispecific antibody that mimics the function of clotting factor VIII, used to prevent or reduce bleeding episodes in people with hemophilia A, including those with factor VIII inhibitors.
Attributes
Product Content
How to Use:
• Administered only by a doctor or nurse (or self-administered after training) by subcutaneous injection.
• Dose and frequency are decided by your doctor; usually starts weekly then spaces out.
• Report any unusual clotting symptoms to your doctor.
• Prescription medicine; take exactly as prescribed and consult your doctor before use.
The link to Hemlibra 60mg/0.4ml Subcutaneous 1 Vial (Refrigerated) has been copied